A detailed history of Mercer Global Advisors Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Mercer Global Advisors Inc holds 4,629 shares of RDY stock, worth $352,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,629
Previous 5,783 19.96%
Holding current value
$352,359
Previous $402,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$67.36 - $77.59 $77,733 - $89,538
-1,154 Reduced 19.96%
4,629 $335,000
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $148,913 - $161,958
2,317 Added 66.85%
5,783 $402,000
Q3 2023

Nov 13, 2023

SELL
$61.9 - $72.77 $5,509 - $6,476
-89 Reduced 2.5%
3,466 $232,000
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $189,623 - $224,356
3,555 New
3,555 $224,000
Q2 2022

Aug 10, 2022

SELL
$49.62 - $58.13 $14,886 - $17,439
-300 Reduced 7.38%
3,767 $209,000
Q1 2022

May 10, 2022

SELL
$48.27 - $65.25 $23,362 - $31,581
-484 Reduced 10.64%
4,067 $227,000
Q4 2021

Feb 04, 2022

SELL
$59.5 - $67.25 $14,756 - $16,678
-248 Reduced 5.17%
4,551 $298,000
Q3 2021

Nov 10, 2021

SELL
$60.19 - $75.29 $62,116 - $77,699
-1,032 Reduced 17.7%
4,799 $313,000
Q2 2021

Aug 10, 2021

BUY
$62.12 - $74.2 $37,893 - $45,262
610 Added 11.68%
5,831 $429,000
Q1 2021

May 11, 2021

BUY
$57.98 - $73.08 $32,236 - $40,632
556 Added 11.92%
5,221 $321,000
Q4 2020

Feb 12, 2021

BUY
$62.61 - $71.29 $69,434 - $79,060
1,109 Added 31.19%
4,665 $333,000
Q3 2020

Dec 10, 2020

BUY
$51.39 - $72.41 $182,742 - $257,489
3,556 New
3,556 $247,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.